Verzenio 50 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26F9ARU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,070
Award facts
- Contract value 100% obligated
- $28,069.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,069.94 delivery order to AmerisourceBergen Drug Corp for Verzenio 50 mg tablets (14-tablet units) on December 2, 2025, with completion expected by December 3, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. Verzenio is a prescription oncology medication used in breast cancer treatment, reflecting the company's capability to provide specialized therapeutic medications alongside routine pharmaceutical commodities. As a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen maintains the operational capacity to fulfill diverse medical supply requirements across multiple therapeutic domains, positioning it as an essential component of the federal supply chain for the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F9ARU?
SPE2DR26F9ARU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9ARU worth?
The government has obligated $28,070 on SPE2DR26F9ARU.
Is contract SPE2DR26F9ARU an order under another contract?
Yes. SPE2DR26F9ARU is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9ARU competed?
The extent of competition for SPE2DR26F9ARU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award